Treatment and Management of Interstitial Lung Disease (ILD)

A panel of expert discuss interstitial lung disease (ILD) in depth, from definition to the best possible therapy options for treatment.

EP. 1: Interstitial Lung Disease: An Overview

April 11th 2022

Paul Noble, MD, and Daniel Culver, DO, explain the definition of interstitial lung disease (ILD), as well as certain conditions that fall within that distinction.

EP. 2: ILD Risk Factors

April 11th 2022

Kristin Highland, MD, discusses the common risk factors associated with ILD.

EP. 3: Incidence and Prevalence For ILD

June 7th 2022

Daniel Culver, DO, and Paul Noble, MD, talk about incidence and prevalence typically seen with patients with ILD.

EP. 4: Who is Diagnosing and Treating ILD?

June 7th 2022

Daniel Culver, DO, and Paul Noble, MD, highlight the types of physicians who manage patients with different forms of ILD, from diagnosis to treatment, as well as the process of referrals.

EP. 5: ILD Clinical and Economic Burden

June 14th 2022

Ryan Haumschild, PharmD, MS, MBA, and Kristin Highland, MD, explain the clinical and economic burdens associated with ILD treatment.

EP. 6: Treatment Goals for Patients With ILD

June 14th 2022

Drs Noble and Highland explain the typical treatment goals physicians aim for when looking at ILD therapy options.

EP. 7: IPF, PF-ILD Treatment Landscape

June 21st 2022

The panel provides an overview of the treatment landscape for idiopathic pulmonary fibrosis (IPF) and progressing fibrosing ILD (PF-ILD).

EP. 8: SSc-ILD Treatment Landscape and Clinical Trials

June 21st 2022

Dr Kristin Highland continues the treatment landscape discussion, focusing on systemic sclerosis ILD (SSc-ILD) and clinical trial data that studied therapy options for IPF, PF-ILD, and SSc-ILD.